Highly expressed genes in rapidly proliferating tumor cells as new targets for colorectal cancer treatment

Clinical Cancer Research

Volumn 21, Issue 16, 2015, Pages 3695-3704

  Bazzocco, Sarah ^a,b   Dopeso, Higinio ^a,b   Carton Garcia, Fernando ^a,b   Macaya, Irati ^a,b   Andretta, Elena ^a,b   Chionh, Fiona ^c   Rodrigues, Paulo ^a,b   Garrido, Miriam ^a   Alazzouzi, Hafid ^a,b   Nieto, Rocio ^a,b   Sanchez, Alex ^a,d   Schwartz, Simo ^a,b   Bilic, Josipa ^a,b   Mariadason, John M ^c   Arango, Diego ^a,b  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^d UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACIFLUORFEN; FLUOROURACIL; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; IODOACETIC ACID; OXIDOREDUCTASE INHIBITOR; PROTOPORPHYRINOGEN OXIDASE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; FLAVOPROTEIN; MITOCHONDRIAL PROTEIN; NITROBENZOIC ACID DERIVATIVE; PPOX PROTEIN, HUMAN; TUMOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; COLORECTAL CANCER; COLORECTAL CANCER CELL LINE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GROWTH RATE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MALE; MICROARRAY ANALYSIS; MICROSATELLITE INSTABILITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR DIFFERENTIATION; TUMOR XENOGRAFT; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL CYCLE; COLORECTAL NEOPLASMS; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; HCT116 CELL LINE; MOLECULARLY TARGETED THERAPY; PATHOLOGY; PROTEIN TRANSPORT; RNA SPLICING; SIGNAL TRANSDUCTION;

ANIMALS; CELL CYCLE; CELL PROLIFERATION; COLORECTAL NEOPLASMS; FEMALE; FLAVOPROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HCT116 CELLS; HUMANS; MALE; MICE; MITOCHONDRIAL PROTEINS; MOLECULAR TARGETED THERAPY; NEOPLASM PROTEINS; NITROBENZOATES; PROTEIN TRANSPORT; PROTOPORPHYRINOGEN OXIDASE; RNA SPLICING; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84943144330     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-14-2457     Document Type: Article

References (36)

1. Jemal A, Bray F, Ferlay J. Global Cancer Statistics. CA Cancer J Clin 2011;61:69-90.
2. Network TCGA. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012;487:330-7.
3. Bernstein BE, Birney E, Dunham I, Green ED, Gunter C, Snyder M. An integrated encyclopedia of DNA elements in the human genome. Nature 2012;489:57-74.
4. Whitfield ML, Sherlock G, Saldanha AJ, Murray JI, Ball CA, Alexander KE, et al. Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Mol Biol Cell 2002;13:1977-2000.
5. Cho RJ, Huang M, Campbell MJ, Dong H, Steinmetz L, Sapinoso L, et al. Transcriptional regulation and function during the human cell cycle. Nat Genet 2001;27:48-54.
6. Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, et al. Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc Natl Acad Sci USA 2004;101:9309-14.
7. Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P, et al. Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 2000;24:227-35.
8. Waldman YY, Geiger T, Ruppin E. A genome-wide systematic analysis reveals different and predictive proliferation expression signatures of cancerous vs. non-cancerous cells. PLoS Genet 2013;9:e1003806.
9. Sinicrope FA, Hart J, Hsu HA, Lemoine M, Michelassi F, Stephens LC. Apoptotic andmitotic indices predict survival rates in lymph node-negative colon carcinomas. Clin Cancer Res 1999;5:1793-804.
10. al-Sheneber IF, Shibata HR, Sampalis J, Jothy S. Prognostic significance of proliferating cell nuclear antigen expression in colorectal cancer. Cancer 1993;71:1954-9.
11. Mayer A, Takimoto M, Fritz E, Schellander G, Kofler K, Ludwig H. The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer. Cancer 1993;71:2454-60.
12. Kovac D, Rubinic M, Krasevic M, Krizanac S, Petrovecki M, Stimac D, et al. Proliferating cell nuclear antigen (PCNA) as a prognostic factor for colorectal cancer. Anticancer Res 1995;15:2301-2.
13. Heidelberger C, Chaudhuri NK, Danneberg P, Mooren D, Griesbach L, Duschinsky R, et al. Fluorinated pyrimidines, a new class of tumourinhibitory compounds. Nature 1957;179:663-6.
14. Ke N, Wang X, Xu X, Abassi YA. The xCELLigence system for real-time and label-free monitoring of cell viability. Methods Mol Biol 2011;740:33-43.
15. Mariadason JM, Arango D, Shi Q, Wilson AJ, Corner GA, Nicholas C, et al. Gene expression profiling-based prediction of response of colon carcinoma cells to 5-fluorouracil and camptothecin. Cancer Res 2003;63:8791-812.
16. Dopeso H, Mateo-Lozano S, Elez E, Landolfi S, Ramos Pascual FJ, Hernández-Losa J, et al. Aprataxin tumor levels predict response of colorectal cancer patients to irinotecan-based treatment. Clin Cancer Res 2010;16:2375-82.
17. Monks A, Scudiero D, Skehan P, Shoemaker R, Paull K, Vistica D, et al. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J Natl Cancer Inst 1991;83:757-66.
18. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 1990;82:1107-12.
19. Arango D, Laiho P, Kokko A, Alhopuro P, Sammalkorpi H, Salovaara R, et al. Gene-expression profiling predicts recurrence in Dukes' C colorectal cancer. Gastroenterology 2005;129:874-84.
20. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003;4:249-64.
21. Li C, Wong WH. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci U S A 2001;98:31-6.
22. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009;4:44-57.
23. Boland CR, Goel A. Microsatellite instability in colorectal cancer. Gastroenterology 2010;138:2073-87.e3.
24. Saleh H, Jackson H, Khatib G, Banerjee M. Correlation of bcl-2 oncoprotein immunohistochemical expression with proliferation index and histopathologic parameters in colorectal neoplasia. Pathol Oncol Res 1999;5:273-9.
25. Georgescu CV, Sàftoiu A, Georgescu CC, Ciurea R, Ciurea T. Correlations of proliferation markers, p53 expression and histological findings in colorectal carcinoma. J Gastrointestin Liver Dis 2007;16:133-9.
26. Michael-Robinson JM, Reid LE, Purdie DM, Walsh MD, Pandeya N, Simms LA, et al. Proliferation, apoptosis, and survival in high-level microsatellite instability sporadic colorectal cancer. Clin Cancer Res 2001;7:2347-56.
27. Mouradov D, Sloggett C, Jorissen RN, Love CG, Li S, Burgess AW, et al. Colorectal cancer cell lines are representative models of themain molecular subtypes of primary cancer. Cancer Res 2014;74:3238-47.
28. Padmanaban G, Venkateswar V, Rangarajan PN. Haem as a multifunctional regulator. Trends Biochem Sci 1989;14:492-6.
29. Hooda J, Cadinu D, Alam MM, Shah A, Cao TM, Sullivan L a, et al. Enhanced heme function and mitochondrial respiration promote the progression of lung cancer cells. PLoS ONE 2013;8:e63402.
30. Warburg O. Injuring of respiration the origin of cancer cells. Science 1956;123:309-14.
31. Tennant DA, Durán R V, Gottlieb E. Targetingmetabolic transformation for cancer therapy. Nat Rev Cancer 2010;10:267-77.
32. Kroemer G, Pouyssegur J. Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell 2008;13:472-82.
33. Zheng L, Roeder RG, Luo Y. S phase activation of the histone H2B Promoter by OCA-S, a coactivator complex that contains GAPDH as a key component. Cell Elsevier 2003;114:255-66.
34. Hara MR, Agrawal N, Kim SF, Cascio MB, Fujimuro M, Ozeki Y, et al. Snitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding. Nat Cell Biol 2005;7:665-74.
35. Sánchez-Aragó M, Cuezva JM. The bioenergetic signature of isogenic colon cancer cells predicts the cell death response to treatment with 3-bromopyruvate, iodoacetate or 5-fluorouracil. J Transl Med 2011;9:19.
36. Fahim FA, Esmat AY, Mady EA, Ibrahim EK. Antitumor activities of iodoacetate and dimethylsulphoxide against solid Ehrlich carcinoma growth in mice. Biol Res 2003;36:253-62.